BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kerr JR. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. J Clin Pathol 2019;72:651-8. [DOI: 10.1136/jclinpath-2019-205822] [Cited by in Crossref: 26] [Cited by in F6Publishing: 41] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Schneider-Hohendorf T, Gerdes LA, Pignolet B, Gittelman R, Ostkamp P, Rubelt F, Raposo C, Tackenberg B, Riepenhausen M, Janoschka C, Wünsch C, Bucciarelli F, Flierl-Hecht A, Beltrán E, Kümpfel T, Anslinger K, Gross CC, Chapman H, Kaplan I, Brassat D, Wekerle H, Kerschensteiner M, Klotz L, Lünemann JD, Hohlfeld R, Liblau R, Wiendl H, Schwab N. Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. J Exp Med 2022;219:e20220650. [PMID: 36048016 DOI: 10.1084/jem.20220650] [Reference Citation Analysis]
2 Ara T, Endo T, Goto H, Kasahara K, Hasegawa Y, Yokoyama S, Shiratori S, Nakagawa M, Kuwahara K, Takakuwa E, Hashino S, Teshima T. Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor. Antiviral Therapy 2022;27:135965352211268. [DOI: 10.1177/13596535221126828] [Reference Citation Analysis]
3 Musukuma-chifulo K, Siddiqi OK, Chilyabanyama ON, Bates M, Chisenga CC, Simuyandi M, Sinkala E, Dang X, Koralnik IJ, Chilengi R, Munsaka S. Epstein–Barr Virus Detection in the Central Nervous System of HIV-Infected Patients. Pathogens 2022;11:1080. [DOI: 10.3390/pathogens11101080] [Reference Citation Analysis]
4 Qiu L, Si J, Kang J, Chen Z, Nuermaimaiti R, Qian Z, Li L, Zhou S, You MJ, Zhang H, Tian C. A retrospective analysis of EBV-DNA status with the prognosis of lymphoma. J Cell Mol Med 2022. [PMID: 36065965 DOI: 10.1111/jcmm.17543] [Reference Citation Analysis]
5 Khan T, Rahman M, Ahmed I, Al Ali F, Jithesh PV, Marr N. Human leukocyte antigen class II gene diversity tunes antibody repertoires to common pathogens. Front Immunol 2022;13:856497. [DOI: 10.3389/fimmu.2022.856497] [Reference Citation Analysis]
6 Muhealdeen DN, Shwan A, Yaqo RT, Hassan HA, Muhammed BO, Ali RM, Hughson MD. Epstein-Barr virus and Burkitt's lymphoma. Associations in Iraqi Kurdistan and twenty-two countries assessed in the International Incidence of Childhood Cancer. Infect Agent Cancer 2022;17:39. [PMID: 35897021 DOI: 10.1186/s13027-022-00452-0] [Reference Citation Analysis]
7 Kunstek H, Vreken F, Keita A, Hamblin MR, Dumarçay F, Varbanov M. Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light. Pharmaceuticals 2022;15:858. [DOI: 10.3390/ph15070858] [Reference Citation Analysis]
8 Qin N, Zhang Y, Xu L, Liu W, Luo B. Maintenance of Epstein-Barr virus latency through interaction of LMP2A with CXCR4. Arch Virol 2022. [PMID: 35752684 DOI: 10.1007/s00705-022-05511-w] [Reference Citation Analysis]
9 Yu H, Bai S, Hao Y, Guan Y. Fatty acids role in multiple sclerosis as "metabokines". J Neuroinflammation 2022;19:157. [PMID: 35715809 DOI: 10.1186/s12974-022-02502-1] [Reference Citation Analysis]
10 Zhang XY, Teng QB. Recurrence of infectious mononucleosis in adults after remission for 3 years: A case report. World J Clin Cases 2022; 10(12): 3951-3958 [DOI: 10.12998/wjcc.v10.i12.3951] [Reference Citation Analysis]
11 Meng M, Zhang S, Dong X, Sun W, Deng Y, Li W, Li R, Annane D, Wu Z, Chen D. COVID-19 associated EBV reactivation and effects of ganciclovir treatment. Immun Inflamm Dis 2022;10:e597. [PMID: 35349757 DOI: 10.1002/iid3.597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Yi W, Zhang C, Xu C, Tian W, Xie F, Yue B, Velmurugan P. Therapeutic Effect of Bicyclol Coupled with Aspirin Nanopreparation on Liver Function Damage Caused by Epstein-Barr Virus Infection in Children. Journal of Nanomaterials 2022;2022:1-8. [DOI: 10.1155/2022/9609398] [Reference Citation Analysis]
13 van Eijk LE, Koldijk MJ, van Kester MS, Diepstra A, Diercks GFH. A Rare Case of Epstein-Barr Virus-Positive T-Cell Lymphoma in the Skin of an Immunocompromised Patient. Am J Dermatopathol 2022;44:e19-22. [PMID: 35076433 DOI: 10.1097/DAD.0000000000002048] [Reference Citation Analysis]
14 Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L. Epstein-Barr Virus and Neurological Diseases. Front Mol Biosci 2022;8:816098. [DOI: 10.3389/fmolb.2021.816098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Wang Y, Yang J, Wen Y. Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients. Biomed Pharmacother 2022;145:112392. [PMID: 34781140 DOI: 10.1016/j.biopha.2021.112392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bakal DR, Kasitinon D, Kussman AL, Hwang CE. Splenomegaly from Recurrent Infectious Mononucleosis in an NCAA Division I Athlete. Curr Sports Med Rep 2021;20:511-3. [PMID: 34622813 DOI: 10.1249/JSR.0000000000000887] [Reference Citation Analysis]
17 Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules 2021;11:1380. [PMID: 34572593 DOI: 10.3390/biom11091380] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
18 Rosseto JHF, Tenório JR, Mamana AC, Tozetto-Mendoza TR, Andrade NS, Braz-Silva PH, Ortega KL. Epstein-Barr virus oral shedding and viremia and their association with oral hairy leukoplakia in HIV+ individuals. Oral Dis 2021. [PMID: 34379873 DOI: 10.1111/odi.14001] [Reference Citation Analysis]
19 Trompet E, Temblador A, Gillemot S, Topalis D, Snoeck R, Andrei G. An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness. Viruses 2021;13:985. [PMID: 34073189 DOI: 10.3390/v13060985] [Reference Citation Analysis]
20 Wormser GP. Documentation of a false positive Lyme disease serologic test in a patient with untreated Babesia microti infection carries implications for accurately determining the frequency of Lyme disease coinfections. Diagn Microbiol Infect Dis 2021;101:115429. [PMID: 34133997 DOI: 10.1016/j.diagmicrobio.2021.115429] [Reference Citation Analysis]
21 Lee J, Stone J, Desai P, Kosowicz JG, Liu JO, Ambinder RF. Arsenicals, the Integrated Stress Response, and Epstein-Barr Virus Lytic Gene Expression. Viruses 2021;13:812. [PMID: 33946406 DOI: 10.3390/v13050812] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Montoya-Ferrer A, Sanosyan A, Fayd'herbe de Maudave A, Pisoni A, Bollore K, Molès JP, Peries M, Tylleskar T, Tumwine JK, Ndeezi G, Gorgolas M, Nagot N, van de Perre P, Tuaillon E. Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda. Clin Infect Dis 2021;72:1026-32. [PMID: 32067040 DOI: 10.1093/cid/ciaa161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kulkarni R, Basheer A, Khan A. Coombs-Negative Haemolytic Anaemia, Direct Hyperbilirubinaemia and Splenomegaly: A Rare Amalgam. Eur J Case Rep Intern Med 2021;8:002477. [PMID: 33987128 DOI: 10.12890/2021_002477] [Reference Citation Analysis]
24 Li X, Zhang W. Expression of PD-L1 in EBV-associated malignancies. Int Immunopharmacol 2021;95:107553. [PMID: 33765613 DOI: 10.1016/j.intimp.2021.107553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Kim JH, Kim WS, Park C. Sildenafil prevents HDACi-induced Epstein-Barr virus reactivation through the PKG pathway in NK/T cell lymphoma; potential implications for HDACi-mediated fatal complications. Antiviral Res 2021;189:105063. [PMID: 33741394 DOI: 10.1016/j.antiviral.2021.105063] [Reference Citation Analysis]
26 Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story. Viruses 2021;13:277. [PMID: 33670195 DOI: 10.3390/v13020277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
27 Long C, Xu QB, Ding L, Yang L, Ji W, Gao F, Ji Y. Triptolide inhibits human telomerase reverse transcriptase by downregulating translation factors SP1 and c-Myc in Epstein-Barr virus-positive B lymphocytes. Oncol Lett 2021;21:280. [PMID: 33732356 DOI: 10.3892/ol.2021.12541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Koganti R, Yadavalli T, Naqvi RA, Shukla D, Naqvi AR. Pathobiology and treatment of viral keratitis. Exp Eye Res 2021;205:108483. [PMID: 33556334 DOI: 10.1016/j.exer.2021.108483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
30 Lankenau-Vela D, De la Garza-Salazar F, Colunga-Pedraza P, Jaime-Villalón D. Interferon-alpha-2a as a salvage treatment for hemorrhagic enteritis associated with Epstein-Barr Virus reactivation: a case report. Acta Gastroenterol Belg 2021;84:129-30. [PMID: 33639704 DOI: 10.51821/84.1.658] [Reference Citation Analysis]
31 Olsson T. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis. Eur J Immunol 2021;51:56-9. [PMID: 33350470 DOI: 10.1002/eji.202049030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Houen G, Trier NH, Frederiksen JL. Epstein-Barr Virus and Multiple Sclerosis. Front Immunol 2020;11:587078. [PMID: 33391262 DOI: 10.3389/fimmu.2020.587078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
33 Hatayama Y, Hashimoto Y, Motokura T. Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapy. J Int Med Res 2020;48:300060520972880. [PMID: 33249964 DOI: 10.1177/0300060520972880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Liu W, Li H, Sheng H, Liu X, Chi P, Wang X, Mao M. A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma. Adv Ther 2020;37:4280-90. [PMID: 32780356 DOI: 10.1007/s12325-020-01461-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Xu S, Chen H, Zu X, Hao X, Feng R, Zhang S, Chen B, Zeng Z, Chen M, Ye Z, He Y. Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area. Therap Adv Gastroenterol 2020;13:1756284820930124. [PMID: 32913442 DOI: 10.1177/1756284820930124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Zhang P, Yang Y, Zou J, Yang X, Liu Q, Chen Y. Seizures and epilepsy secondary to viral infection in the central nervous system. Acta Epileptologica 2020;2. [DOI: 10.1186/s42494-020-00022-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
37 So TY, Ai QH, Lam WKJ, Qamar S, Poon DMC, Hui EP, Mo FKF, Chan KCA, King AD. Intravoxel incoherent motion diffusion-weighted imaging for discrimination of benign and malignant retropharyngeal nodes. Neuroradiology 2020;62:1667-76. [PMID: 32676831 DOI: 10.1007/s00234-020-02494-w] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Cunningham ET, Zierhut M. Epstein-Barr Virus and the Eye. Ocular Immunology and Inflammation 2020;28:533-7. [DOI: 10.1080/09273948.2020.1760549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Anderson G, Maes M. Mitochondria and immunity in chronic fatigue syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2020;103:109976. [PMID: 32470498 DOI: 10.1016/j.pnpbp.2020.109976] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
40 Nakamura H, Shimizu T, Kawakami A. Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1. J Clin Med 2020;9:E1459. [PMID: 32414149 DOI: 10.3390/jcm9051459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
41 Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, Patrizio A, Giusti C, Gonnella D, Cristaudo A, Foddis R, Shoenfeld Y, Fallahi P. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab 2020;34:101387. [PMID: 32107168 DOI: 10.1016/j.beem.2020.101387] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
42 Maple PAC. Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development. Vaccines (Basel) 2020;8:E35. [PMID: 31968673 DOI: 10.3390/vaccines8010035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]